✉news WorldLaw & Courts first seen 12 h ago, last 9 min ago, peak #3
Liquidia shares fall after court rules for United Therapeutics in patent case
Original: Liquidia slumps after US court rules for United Therapeutics in patent fight
Liquidia shares dropped after a US court sided with United Therapeutics in a patent dispute between the two pharmaceutical companies. The ruling is a setback for Liquidia, whose lead product competes with United Therapeutics' treatments for pulmonary arterial hypertension. Investors reacted quickly, sending the stock lower as the market assessed the implications for Liquidia's commercial prospects.
Why now: A US court ruling favoring United Therapeutics triggered a sharp decline in Liquidia's share price.
Rank over time, top of the chart is #1. 10 snapshots from 12 h ago to 9 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/532955